购物车
- 全部删除
- 您的购物车当前为空
JNJ-26076713, an orally active alpha V integrin antagonist, represents a potential therapeutic candidate for the treatment of macular edema, age-related macular degeneration, and proliferative diabetic retinopathy.
JNJ-26076713, an orally active alpha V integrin antagonist, represents a potential therapeutic candidate for the treatment of macular edema, age-related macular degeneration, and proliferative diabetic retinopathy.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 37,400 | 8-10周 |
产品描述 | JNJ-26076713, an orally active alpha V integrin antagonist, represents a potential therapeutic candidate for the treatment of macular edema, age-related macular degeneration, and proliferative diabetic retinopathy. |
别名 | JNJ26076713 |
分子量 | 490.64 |
分子式 | C29H38N4O3 |
CAS No. | 669076-03-3 |
密度 | 1.31 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
评论内容